The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of a high-throughput molecular tumor board (MTB) to provide clinical practice guidance following comprehensive molecular profiling (CMP).
 
Ari M. Vanderwalde
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caris Life Sciences; Genentech
Research Funding - Amgen; AstraZeneca; Genentech/Roche; Lilly; Merck; Millennium; Polynoma
 
Gy Won Choi
No Relationships to Disclose
 
Gregory A. Vidal
Consulting or Advisory Role - Lilly
Speakers' Bureau - Pfizer
Research Funding - AstraZeneca; Genentech/Roche; GTx; Lilly; Merck; Newlink Genetics; Puma Biotechnology
 
Jason Claud Chandler
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Janssen
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech/Roche; GlaxoSmithKline; Lilly; Onyx
 
Bradley G. Somer
Research Funding - Aragon Pharmaceuticals; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; GlaxoSmithKline; Incyte; Merck; Millennium; Newlink Genetics; OncoGenex; Roche/Genentech; Wellstat Therapeutics
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Stock and Other Ownership Interests - Vector Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Genentech; Teva
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Eisai